AstraZeneca
  1. Companies
  2. AstraZeneca
  3. Products
  4. Model AZD2373 Phase I - Nephropathy

Model AZD2373 Phase I - Nephropathy

SHARE

Mechanism: Podocyte health; Area under investigation: nephropathy; Date commenced phase: Q1 2020; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule; Status change.

Most popular related searches